Moderna Inc (MRNA)
38.26
+1.32
(+3.57%)
USD |
NASDAQ |
Nov 21, 16:00
38.21
-0.05
(-0.13%)
After-Hours: 20:00
Moderna Gross Profit Margin (Quarterly): 72.29% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 72.29% |
| June 30, 2024 | 47.96% |
| March 31, 2024 | 42.52% |
| December 31, 2023 | 66.97% |
| September 30, 2023 | -25.41% |
| June 30, 2023 | -131.3% |
| March 31, 2023 | 56.91% |
| December 31, 2022 | 62.75% |
| Date | Value |
|---|---|
| September 30, 2022 | 65.84% |
| June 30, 2022 | 69.75% |
| March 31, 2022 | 82.88% |
| December 31, 2021 | 86.30% |
| September 30, 2021 | 85.05% |
| June 30, 2021 | 82.21% |
| March 31, 2021 | 88.93% |
| December 31, 2020 | 96.51% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-131.3%
Minimum
Jun 2023
96.51%
Maximum
Dec 2020
53.13%
Average
68.36%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 81.02% |
| Merck & Co Inc | 75.51% |
| Pfizer Inc | 70.27% |
| Novavax Inc | 28.27% |
| Vertex Pharmaceuticals Inc | 85.84% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -17.44% |
| Return on Assets | -12.92% |
| Return on Invested Capital | -17.44% |
| Profit Margin (Quarterly) | 0.70% |
| Operating Margin (Quarterly) | -3.77% |
| Return on Net Operating Assets | -45.55% |